Physician profile
Michael D Lichter
NPI 1962572305
$53,478.80
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $6,685 · 2021: $8,438 · 2022: $13K.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $45,819.85 | 2019-2022 | |
| Leo Pharma INC. | $1,554.25 | 2019-2022 | |
| Amgen INC. | $1,049.33 | 2020-2022 | |
| Janssen Biotech, INC. | $1,044.18 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $867.67 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $436.46 | 2019-2022 | |
| Genzyme Corporation | $415.58 | 2019-2022 | |
| Ucb, INC. | $374.75 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $308.89 | 2019-2020 | |
| Lilly USA, LLC | $298.15 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $225.60 | 2019-2021 | |
| Incyte Corporation | $208.48 | 2022 | |
| Genentech USA, INC. | $166.48 | 2020-2022 | |
| Pfizer INC. | $148.68 | 2019-2022 | |
| Vyne Pharmaceuticals INC. | $106.98 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Helsinn Therapeutics (U.S.), INC. | $102.58 | 2019-2022 | |
| Celgene Corporation | $89.47 | 2019 | |
| Janssen Scientific Affairs, LLC | $89.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $68.76 | 2022 | |
| Galderma Laboratories, L.P. | $40.87 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $29.63 | 2019 | |
| Dermira, INC. | $19.50 | 2019 | |
| Smith+Nephew, INC. | $13.61 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lichter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.